Malfunctioning insulin secretion and/or insulin resistance are recognized as key factors for the pathogenesis of T2DM [61,62]; the latter results from anomalies in the insulin signaling cascade, a regulated complex molecular pathway, which may be inhibited and activated by many biochemical mechanisms [62]. The gene discussed is INS; the disease is Insulin resistance.